BiomX Inc PHGE.U
Trading Information
- Previous Close Price
- $0.27
- Day Range
- $0.41–0.41
- 52-Week Range
- $0.05–0.82
- Bid/Ask
- $0.11 / $1.00
- Market Cap
- $3.70 Mil
- Volume/Avg
- 114 / 3,744
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
BiomX Inc is a clinical-stage microbiome company based in Israel. The company is engaged in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease, colorectal cancer, and primary sclerosing cholangitis. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 71
- Website
- https://www.biomx.com
Valuation
|
Metric
|
PHGE.U
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
PHGE.U
|
|---|---|
Quick Ratio | 1.39 |
Current Ratio | 1.58 |
Interest Coverage | −10.34 |
Quick Ratio
PHGE.U
Profitability
|
Metric
|
PHGE.U
|
|---|---|
Return on Assets (Normalized) | −68.00% |
Return on Equity (Normalized) | −197.03% |
Return on Invested Capital (Normalized) | −80.36% |
Return on Assets
PHGE.U
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Xhkrfmfszh | Gxdb | $586.1 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Zpbcpzlvx | Bclqkbp | $113.7 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Sjlptjq | Zywqqj | $108.2 Bil | |
MRNA
| Moderna Inc | Ztswsrvn | Xbkj | $50.9 Bil | |
ARGX
| argenx SE ADR | Gcbjdyg | Zqtv | $22.0 Bil | |
BNTX
| BioNTech SE ADR | Zpykdnqt | Njkn | $21.8 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Pgncwsswx | Xvjgpz | $18.9 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Pzpnhygsk | Hksjf | $14.6 Bil | |
INCY
| Incyte Corp | Gbykjlgt | Qtcsv | $12.8 Bil | |
RPRX
| Royalty Pharma PLC Class A | Gvjxrkhdh | Pfzxcq | $12.3 Bil |